Cargando…

Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China

OBJECTIVE: To develop a mapping algorithm for generating the Short Form Six-Dimension (SF-6D) utility score based on the Functional Assessment of Cancer Therapy-Lung (FACT-L) of lung cancer patients. METHODS: Data were collected from 625 lung cancer patients in mainland China. The Spearman rank corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qing, Jiang, Long Lin, Li, Yin Feng, Huang, Deyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648360/ https://www.ncbi.nlm.nih.gov/pubmed/37964348 http://dx.doi.org/10.1186/s12955-023-02209-8

Ejemplares similares

Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study
por: Yang, Qing, et al.
Publicado: (2023)

Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N
por: Huang, Deyu, et al.
Publicado: (2023)

Mapping CushingQoL Scores onto SF-6D Utility Values in Patients with Cushing’s Syndrome
por: Roset, Montse, et al.
Publicado: (2013)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?
por: Kharroubi, Samer A
Publicado: (2020)

Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population
por: Kim, Seon-Ha, et al.
Publicado: (2014)

Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
por: Kularatna, Sanjeewa, et al.
Publicado: (2019)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?
por: Kharroubi, Samer A.
Publicado: (2021)

SF-6D utility scores of smokers and ex-smokers with or without respiratory symptoms attending primary care clinics
por: Fu, Sau-nga, et al.
Publicado: (2019)

The Importance of Accounting for Parameter Uncertainty in SF-6D Value Sets and Its Impact on Studies that Use the SF-6D to Measure Health Utility
por: Kharroubi, Samer A., et al.
Publicado: (2020)

A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population
por: McDool, Emily, et al.
Publicado: (2021)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Correction to: A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population
por: McDool, Emily, et al.
Publicado: (2021)

Applying SF-6D to measure health state utilities among the middle and old aged patients with hypertension in China
por: Liu, Xiaohan, et al.
Publicado: (2020)

EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec
por: Poder, Thomas G, et al.
Publicado: (2020)

Validation of the SF-6D Health State Utilities Measure in Lower Extremity Sarcoma
por: Gundle, Kenneth R., et al.
Publicado: (2014)

Mapping the neck disability index to SF-6D in patients with chronic neck pain
por: Zheng, Yongjun, et al.
Publicado: (2016)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials
por: Younossi, Zobair, et al.
Publicado: (2017)

Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia
por: Meregaglia, Michela, et al.
Publicado: (2017)

Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D
por: Wang, Xiaowen, et al.
Publicado: (2022)

Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease
por: Monroy, Manuel, et al.
Publicado: (2018)

Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China
por: Yang, Qing, et al.
Publicado: (2019)

The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya
por: Patel, Anik R., et al.
Publicado: (2017)

Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China
por: Xie, Shitong, et al.
Publicado: (2023)

Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer
por: Bulamu, Norma B., et al.
Publicado: (2023)

What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D
por: Walters, Stephen J, et al.
Publicado: (2003)

Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg)
por: Sun, Sun, et al.
Publicado: (2022)

Predictors of health state utility values using SF-6D for Chinese adult patients with β-thalassemia major
por: Zhang, Runqi, et al.
Publicado: (2023)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy‐Lung (FACT‐L) and the FACT‐Lung Symptom Index (FLSI)
por: Juliana, Franceschini, et al.
Publicado: (2010)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

Development of the SF-6Dv2 health utility survey: comprehensibility and patient preference
por: Broderick, Lynne, et al.
Publicado: (2022)

Properties of SF-6D when longitudinal data from 16,398 spine surgery procedures is applied to 9 national SF-6D value sets
por: Joelson, Anders, et al.
Publicado: (2021)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Mapping the Functional Assessment of Cancer Therapy - Breast (FACT-B) to the 5-level EuroQoL group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a Multi-ethnic Asian population
por: Cheung, Yin Bun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jcf2v2mnk6v8jhrhnphqvgie1j